Literature DB >> 3818551

The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: a preliminary report.

R Famularo, T Fenton.   

Abstract

Ten children, aged 7-12 years, were diagnosed by DSM-III criteria for attention deficit disorder (ADD) without hyperactivity. Each child was treated with methylphenidate for one academic grading period. School grades were obtained for the grading periods before, during, and after drug treatment. Correlated t tests revealed that academic performance during drug treatment was significantly superior to that during the preceding grading period (p less than .01) and the period following drug treatment (p less than .001). ADD without hyperactivity may represent a potentially drug-treatable disorder in children.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818551

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Development and functional significance of private speech among attention-deficit hyperactivity disordered and normal boys.

Authors:  L E Berk; M K Potts
Journal:  J Abnorm Child Psychol       Date:  1991-06

2.  Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.

Authors:  Oliver Tucha; Sylvia Prell; Lara Mecklinger; Christiane Bormann-Kischkel; Sabine Kübber; Martin Linder; Susanne Walitza; Klaus W Lange
Journal:  Psychopharmacology (Berl)       Date:  2006-03-07       Impact factor: 4.530

Review 3.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.